Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placebo-controlled, phase 3 trial
阿波那明或安慰剂联合沙利度胺和地塞米松治疗复发或难治性多发性骨髓瘤（CPT-MM301）：一项随机、双盲、安慰剂对照的3期试验
期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-023-11489-8
Xia, Zhongjun; Leng, Yun; Fang, Baijun; Liang, Yang; Li, Wei; Fu, Chengcheng; Yang, Linhua; Ke, Xiaoyan; Jiang, Hua; Weng, Jianyu; Liu, Li; Zhao, Yaozhong; Zhang, Xuejun; Huang, Zhongxia; Liu, Aichun; Shi, Qingzhi; Gao, Yuhuan; Chen, Xiequn; Pan, Ling; Cai, Zhen; Wang, Zhao; Wang, Yafei; Fan, Yaqun; Hou, Ming; Ma, Yigai; Hu, Jianda; Liu, Jing; Zhou, Jianfeng; Zhang, Xiaohong; Meng, Haitao; Lu, Xuzhang; Li, Fei; Ren, Hanyun; Huang, Bintao; Shao, Zonghong; Zhou, Hebing; Hu, Yu; Yang, Shifang; Zheng, Xiangjun; Wei, Peng; Pang, Hongyan; Yu, Wei; Liu, Yuzhang; Gao, Sujun; Yan, Lingzhi; Ma, Yanping; Jing, Hongmei; Du, Juan; Ling, Wei; Zhang, Jingyi; Sui, Weiwei; Wang, Fuxu; Li, Xin; Chen, Wenming
